2021 MedCan Speaker

Rob Mitchell

Chief Executive Officer,
Rua Bioscience

Rob is a highly experienced senior executive, having spent over 30 years in leadership roles for pharmaceutical multinationals. His recent roles include Senior Vice President, Head of Asia Pacific for The Medicines Company and Senior Vice President, Global Innovation Group Leader – Infectious Disease, based in New Jersey. Rob has also held successive positions as Managing Director of Roche Products (NZ), General Manager Roche Thailand and Head of Global Product Strategy, Virology for F Hoffman La Roche in California.  


All Sessions by Rob Mitchell

Day 1 - Industry Summit - 10 February

Time Industry Stream Science Stream
09:50
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran 
Chief Executive Officer, Helius Therapeutics
Rob Mitchell 
Chief Executive Officer, Rua Bioscience
Mark Lucas 
Chief Executive Officer, Cannasouth
Tim Aldridge 
Managing Director, Puro
Mitch Cuevas 
Pharmaceutical Director, Eqalis

More Speakers

Associate Professor Jonathan Arnold

Deputy Academic Director

Graham Gulbransen

Cannabis Consultant, Addiction Specialist, General Practitioner

Richard Keene

Principal